Arundathy Nirmalini Pandite

Title: Arundathy Nirmalini Pandite: Innovator in Cancer Treatment

Introduction

Arundathy Nirmalini Pandite is a prominent inventor based in Research Triangle Park, NC (US). She has made significant contributions to the field of cancer treatment, particularly in the area of mesothelioma. Her innovative approaches have the potential to improve patient outcomes and advance medical science.

Latest Patents

Arundathy holds 1 patent for her work titled "Methods of treating mesothelioma by administration of compounds comprising FGFR1 ECD." This patent outlines methods for treating cancers by administering a fibroblast growth factor receptor 1 (FGFR1) extracellular domain (ECD) and/or an FGFR1 ECD fusion molecule. Additionally, it includes methods that combine these treatments with at least one anti-angiogenic agent, showcasing her commitment to developing effective cancer therapies.

Career Highlights

Throughout her career, Arundathy has worked with notable companies such as Five Prime Therapeutics, Inc. and GlaxoSmithKline Intellectual Property Limited. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Arundathy has had the opportunity to work alongside talented individuals such as David Bellovin and Kevin P. Baker. These collaborations have enriched her research and expanded her impact in the scientific community.

Conclusion

Arundathy Nirmalini Pandite is a trailblazer in cancer treatment innovation. Her dedication to advancing medical science through her patents and collaborations highlights her significant role in the fight against cancer.